S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10

SOC Telemed Stock Forecast, Price & News

-0.06 (-9.36%)
(As of 01/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
466,596 shs
Average Volume
782,506 shs
Market Capitalization
$58.59 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TLMD News and Ratings via Email

Sign-up to receive the latest news and ratings for SOC Telemed and its competitors with MarketBeat's FREE daily newsletter.

SOC Telemed logo

About SOC Telemed

SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's technology platform, Telemed IQ, provides telemedicine programs. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, and teleICU. The company was founded in 2004 and is based in Reston, Virginia.


See More Headlines

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$57.99 million
Book Value
$0.74 per share


Net Income
$-49.85 million
Pretax Margin




Free Float
Market Cap
$58.59 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.11 out of 5 stars

Medical Sector

509th out of 1,419 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

12th out of 21 stocks

Analyst Opinion: 3.4Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

SOC Telemed (NASDAQ:TLMD) Frequently Asked Questions

Is SOC Telemed a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SOC Telemed in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SOC Telemed stock.
View analyst ratings for SOC Telemed
or view top-rated stocks.

When is SOC Telemed's next earnings date?

SOC Telemed is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022.
View our earnings forecast for SOC Telemed

How were SOC Telemed's earnings last quarter?

SOC Telemed, Inc. (NASDAQ:TLMD) released its quarterly earnings results on Friday, November, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.09. The firm had revenue of $26.68 million for the quarter, compared to the consensus estimate of $25.90 million. SOC Telemed had a negative trailing twelve-month return on equity of 49.59% and a negative net margin of 77.17%. During the same quarter in the previous year, the company earned ($0.14) EPS.
View SOC Telemed's earnings history

What guidance has SOC Telemed issued on next quarter's earnings?

SOC Telemed updated its FY 2021 earnings guidance on Friday, December, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $91.50 million-$93.50 million, compared to the consensus revenue estimate of $90.88 million.

What price target have analysts set for TLMD?

4 Wall Street analysts have issued 12-month target prices for SOC Telemed's shares. Their forecasts range from $2.00 to $7.50. On average, they expect SOC Telemed's stock price to reach $4.38 in the next twelve months. This suggests a possible upside of 653.0% from the stock's current price.
View analysts' price targets for SOC Telemed
or view top-rated stocks among Wall Street analysts.

Who are SOC Telemed's key executives?

SOC Telemed's management team includes the following people:
  • Mr. John W. Kalix, CEO & Director (Age 48, Pay $509.22k)
  • Mr. Hai V. Tran, Pres & COO (Age 51, Pay $661.98k)
  • Dr. R. Jason Hallock M.D., Chief Medical Officer (Age 49, Pay $721.69k)
  • Mr. Christopher K. Knibb, Chief Financial Officer (Age 51)
  • Mr. Sean Banerjee, Chief Technology Officer (Age 52)
  • Ms. Erica St. Angel, Chief Information Officer & Sr. VP of Infrastructure
  • Ms. Eunice J. Kim, Gen. Counsel & Corp. Sec. (Age 47)
  • Ms. Meg Hoyecki, VP of Marketing
  • Ms. Stephanie Tamburello Harris, Chief HR Officer
  • Dr. Alberto Peñalver, Chief of Psychiatry

What is SOC Telemed's stock symbol?

SOC Telemed trades on the NASDAQ under the ticker symbol "TLMD."

Who are SOC Telemed's major shareholders?

SOC Telemed's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.58%), CAPROCK Group Inc. (0.07%) and Index Fund Advisors Inc. (0.06%).

Which major investors are selling SOC Telemed stock?

TLMD stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

Which major investors are buying SOC Telemed stock?

TLMD stock was bought by a variety of institutional investors in the last quarter, including CAPROCK Group Inc., and Index Fund Advisors Inc..

How do I buy shares of SOC Telemed?

Shares of TLMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SOC Telemed's stock price today?

One share of TLMD stock can currently be purchased for approximately $0.58.

How much money does SOC Telemed make?

SOC Telemed has a market capitalization of $58.59 million and generates $57.99 million in revenue each year. The company earns $-49.85 million in net income (profit) each year or ($2.31) on an earnings per share basis.

How many employees does SOC Telemed have?

SOC Telemed employs 359 workers across the globe.

What is SOC Telemed's official website?

The official website for SOC Telemed is www.soctelemed.com.

Where are SOC Telemed's headquarters?

How can I contact SOC Telemed?

SOC Telemed's mailing address is 1768 Business Center Drive Suite 100, Reston VA, 20190. The company can be reached via phone at 866-483-9690.

This page was last updated on 1/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.